BioHarvest Sciences Inc. Files October 2024 6-K Report

Ticker: BHST · Form: 6-K · Filed: Oct 16, 2024

Sentiment: neutral

Topics: regulatory-filing, corporate-history, foreign-private-issuer

TL;DR

BIOHARVEST SCIENCES INC. (BHSC) filed its October 6-K, confirming its Canadian base and 20-F filing status.

AI Summary

BioHarvest Sciences Inc. filed a Form 6-K on October 16, 2024. The company, previously known as Midnight Star Ventures Corp. and Canna-V-Cell Sciences Inc., is incorporated in Canada and has its principal executive offices in Vancouver, British Columbia. This filing is for the month of October 2024 and indicates the company files annual reports under Form 20-F.

Why It Matters

This filing provides an update on BioHarvest Sciences Inc.'s regulatory status and corporate history, which is important for investors tracking the company's compliance and evolution.

Risk Assessment

Risk Level: low — This filing is a routine disclosure and does not contain significant new financial or operational information that would inherently increase risk.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of October 2024.

What are the former names of BioHarvest Sciences Inc.?

BioHarvest Sciences Inc. was formerly known as Midnight Star Ventures Corp. and Canna-V-Cell Sciences Inc.

Where are BioHarvest Sciences Inc.'s principal executive offices located?

The principal executive offices are located at 1140-625 Howe Street, Vancouver, British Columbia, V6C 2T6, Canada.

Does BioHarvest Sciences Inc. file annual reports under Form 20-F or Form 40-F?

The company indicates it files annual reports under cover of Form 20-F.

What is the SIC code for BioHarvest Sciences Inc.?

The Standard Industrial Classification (SIC) code for BioHarvest Sciences Inc. is 2834, Pharmaceutical Preparations.

Filing Stats: 204 words · 1 min read · ~1 pages · Grade level 18 · Accepted 2024-10-16 13:39:56

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOHARVEST SCIENCES INC. (Registrant) Date: October 16, 2024 /s/ David Ryan Name: David Ryan Title: Vice-President, Investor Relations & Secretary

View on Read The Filing